Reboxetine Alcohol

CijHkjO 104-54-1) see Chloramphenicol Zipeprol rrans-cinnamyl alcohol (C HiqO 4407-36-7) see Reboxetine cinnamyl bromide... 

For treatment-resistant patients who do not respond to SSRIs or TCAs, or to the combination of TCAs/SSRIs with benzodiazepines, other antidepressants have shown at least some beneficial effects in alleviating PD symptoms (e.g. mirtazapine, moclobemide, nefazodone, phenelzine, reboxetine, and venlafaxine). Other agents have also been reported to exert beneficial effects in PD, especially when combined with SSRIs/TCAs (lithium, pindolol, and propranolol). In cases where all treatments have failed, valproate or olanzapine should be considered.2 - ° In order to optimize treatment, patients should avoid or reduce the consumption of compounds that could potentially induce/exacerbate panic attacks (e.g. caffeine, alcohol, and nicotine) and should exercise regularly. i... 

A study in 10 healthy subjects found that reboxetine does not affect cognitive or psychomotor function, and there is no interaction with alcohol. ... 

Keir JS, Powell J, Hindmarch 1. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Phamiacol ( 996) 42, 239-41. 

Henegar et al. [78] at Pfizer developed an efficient and greener synthesis of the (S, 5)-reboxetine 157, which is being evaluated for the treatment of neuropathic pain and a variety of other indications (Scheme 9.42). The reported chiral synthesis of 157 starts by SAE of cinnamyl alcohol 154 to give R, R)-epoxide 155 in 89% yield (> 98% ee). Reaction of 155 with 2-ethoxyphenol gave crystallized product 156. The overall yield of (S, 5)-reboxetine succinate increased by 9%, compared to resolution method. The catalytic asymmetric process offers use of less solvent and reduces waste generation by approximately 50%, compared to the resolution route. 

---